BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11290401)

  • 1. Glycogen synthase kinase-3beta immunoreactivity is reduced in the prefrontal cortex in schizophrenia.
    Beasley C; Cotter D; Khan N; Pollard C; Sheppard P; Varndell I; Lovestone S; Anderton B; Everall I
    Neurosci Lett; 2001 Apr; 302(2-3):117-20. PubMed ID: 11290401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An investigation of the Wnt-signalling pathway in the prefrontal cortex in schizophrenia, bipolar disorder and major depressive disorder.
    Beasley C; Cotter D; Everall I
    Schizophr Res; 2002 Nov; 58(1):63-7. PubMed ID: 12363391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Akt participation in the Wnt signaling pathway through Dishevelled.
    Fukumoto S; Hsieh CM; Maemura K; Layne MD; Yet SF; Lee KH; Matsui T; Rosenzweig A; Taylor WG; Rubin JS; Perrella MA; Lee ME
    J Biol Chem; 2001 May; 276(20):17479-83. PubMed ID: 11278246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New steps in the Wnt/beta-catenin signal transduction pathway.
    Sakanaka C; Sun TQ; Williams LT
    Recent Prog Horm Res; 2000; 55():225-36. PubMed ID: 11036939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of Wnt signaling by Axin and Axil.
    Kikuchi A
    Cytokine Growth Factor Rev; 1999; 10(3-4):255-65. PubMed ID: 10647780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disturbance of Notch-1 and Wnt signalling proteins in neuroglial balloon cells and abnormal large neurons in focal cortical dysplasia in human cortex.
    Cotter D; Honavar M; Lovestone S; Raymond L; Kerwin R; Anderton B; Everall I
    Acta Neuropathol; 1999 Nov; 98(5):465-72. PubMed ID: 10541869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin.
    Ikeda S; Kishida S; Yamamoto H; Murai H; Koyama S; Kikuchi A
    EMBO J; 1998 Mar; 17(5):1371-84. PubMed ID: 9482734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt signaling and cancer.
    Polakis P
    Genes Dev; 2000 Aug; 14(15):1837-51. PubMed ID: 10921899
    [No Abstract]   [Full Text] [Related]  

  • 9. Axin, an inhibitor of the Wnt signalling pathway, interacts with beta-catenin, GSK-3beta and APC and reduces the beta-catenin level.
    Nakamura T; Hamada F; Ishidate T; Anai K; Kawahara K; Toyoshima K; Akiyama T
    Genes Cells; 1998 Jun; 3(6):395-403. PubMed ID: 9734785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axin and Frat1 interact with dvl and GSK, bridging Dvl to GSK in Wnt-mediated regulation of LEF-1.
    Li L; Yuan H; Weaver CD; Mao J; Farr GH; Sussman DJ; Jonkers J; Kimelman D; Wu D
    EMBO J; 1999 Aug; 18(15):4233-40. PubMed ID: 10428961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Domains of axin involved in protein-protein interactions, Wnt pathway inhibition, and intracellular localization.
    Fagotto F; Jho Eh; Zeng L; Kurth T; Joos T; Kaufmann C; Costantini F
    J Cell Biol; 1999 May; 145(4):741-56. PubMed ID: 10330403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of Axin in the Wnt signalling pathway.
    Kikuchi A
    Cell Signal; 1999 Nov; 11(11):777-88. PubMed ID: 10617280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a Wnt/beta-catenin signaling pathway in human thyroid cells.
    Helmbrecht K; Kispert A; von Wasielewski R; Brabant G
    Endocrinology; 2001 Dec; 142(12):5261-6. PubMed ID: 11713224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tcf-1-mediated transcription in T lymphocytes: differential role for glycogen synthase kinase-3 in fibroblasts and T cells.
    Staal FJ; Burgering BM; van de Wetering M; Clevers HC
    Int Immunol; 1999 Mar; 11(3):317-23. PubMed ID: 10221643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells.
    Fishman P; Madi L; Bar-Yehuda S; Barer F; Del Valle L; Khalili K
    Oncogene; 2002 Jun; 21(25):4060-4. PubMed ID: 12037688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of glycogen synthase kinase 3beta and downstream Wnt signaling by axin.
    Hedgepeth CM; Deardorff MA; Rankin K; Klein PS
    Mol Cell Biol; 1999 Oct; 19(10):7147-57. PubMed ID: 10490650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bridging of beta-catenin and glycogen synthase kinase-3beta by axin and inhibition of beta-catenin-mediated transcription.
    Sakanaka C; Weiss JB; Williams LT
    Proc Natl Acad Sci U S A; 1998 Mar; 95(6):3020-3. PubMed ID: 9501208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of genomic organisation, sequence variants and analysis of the role of the human dishevelled 1 gene in late onset Alzheimer's disease.
    Russ C; Lovestone S; Powell JF
    Mol Psychiatry; 2002; 7(1):104-9. PubMed ID: 11803455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of antipsychotics on beta-catenin, glycogen synthase kinase-3 and dishevelled in the ventral midbrain of rats.
    Alimohamad H; Sutton L; Mouyal J; Rajakumar N; Rushlow WJ
    J Neurochem; 2005 Oct; 95(2):513-25. PubMed ID: 16144542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt signaling to beta-catenin involves two interactive components. Glycogen synthase kinase-3beta inhibition and activation of protein kinase C.
    Chen RH; Ding WV; McCormick F
    J Biol Chem; 2000 Jun; 275(23):17894-9. PubMed ID: 10749878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.